Anika Therapeutics ANIK Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's deferred tax assets?
- Anika Therapeutics (ANIK) reported deferred tax assets of $1.15M in Q1 2026.
- How has Anika Therapeutics's deferred tax assets changed year-over-year?
- Anika Therapeutics's deferred tax assets decreased by 3.2% year-over-year, from $1.19M to $1.15M.
- What is the long-term trend for Anika Therapeutics's deferred tax assets?
- Over 5 years (2020 to 2025), Anika Therapeutics's deferred tax assets has grown at a -36.0% compound annual growth rate (CAGR), from $11.9M to $1.28M.
- What does deferred tax assets mean?
- Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.